相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is Tau Aggregation Toxic or Protective?
Erin E. Congdon et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Tau, prions and A beta: the triad of neurodegeneration
Lilla Reiniger et al.
ACTA NEUROPATHOLOGICA (2011)
Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity
David X. Medina et al.
BRAIN PATHOLOGY (2011)
Regulation of Response Properties and Operating Range of the AFD Thermosensory Neurons by cGMP Signaling
Sara M. Wasserman et al.
CURRENT BIOLOGY (2011)
A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds
James N. Sleigh et al.
HUMAN MOLECULAR GENETICS (2011)
Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation
Surendra S. Ambegaokar et al.
HUMAN MOLECULAR GENETICS (2011)
Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila
Yasmina Talmat-Amar et al.
HUMAN MOLECULAR GENETICS (2011)
Are Tangles as Toxic as They Look?
Tara L. Spires-Jones et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Optogenetic analysis of GABAB receptor signaling in Caenorhabditis elegans motor neurons
Christian Schultheis et al.
JOURNAL OF NEUROPHYSIOLOGY (2011)
Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant
Astrid Sydow et al.
JOURNAL OF NEUROSCIENCE (2011)
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
Cristian A. Lasagna-Reeves et al.
MOLECULAR NEURODEGENERATION (2011)
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
Stuart A. Sievers et al.
NATURE (2011)
Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan
Silvestre Alavez et al.
NATURE (2011)
Lest we forget you - methylene blue ...
R. Heiner Schirmer et al.
NEUROBIOLOGY OF AGING (2011)
Tau Mediated Neurodegeneration: An Insight into Alzheimer's Disease Pathology
M. Obulesu et al.
NEUROCHEMICAL RESEARCH (2011)
Ageing and protein aggregation-mediated disorders: from invertebrates to mammals
Andrew Dillin et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
Towards a Pharmacophore for Amyloid
Meytal Landau et al.
PLOS BIOLOGY (2011)
A Genetic Screening Strategy Identifies Novel Regulators of the Proteostasis Network
M. Catarina Silva et al.
PLOS GENETICS (2011)
Phosphorylation differentiates tau-dependent neuronal toxicity and dysfunction
Katerina Papanikolopoulou et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
The role of MSUT-2 in tau neurotoxicity: a target for neuroprotection in tauopathy?
Jeanna M. Wheeler et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial
Khalid Iqbal et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
High-throughput screening and small animal models, where are we?
Jean Giacomotto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose
Ivana Sirangelo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Mysterious oligomerization of the amyloidogenic proteins
Vladimir N. Uversky
FEBS JOURNAL (2010)
Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation
Carlo Ballatore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Differential Effects of Tau on the Integrity and Function of Neurons Essential for Learning in Drosophila
Stylianos Kosmidis et al.
JOURNAL OF NEUROSCIENCE (2010)
A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans
Andrew R. Burns et al.
NATURE CHEMICAL BIOLOGY (2010)
Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers
Luisa Diomede et al.
NEUROBIOLOGY OF DISEASE (2010)
Chaperone networks: Tipping the balance in protein folding diseases
Cindy Voisine et al.
NEUROBIOLOGY OF DISEASE (2010)
An Arf-like Small G Protein, ARL-8, Promotes the Axonal Transport of Presynaptic Cargoes by Suppressing Vesicle Aggregation
Matthew P. Klassen et al.
NEURON (2010)
Tau protein and tau aggregation inhibitors
Bruno Bulic et al.
NEUROPHARMACOLOGY (2010)
Coenzyme Q protects Caenorhabditis elegans GABA neurons from calcium-dependent degeneration
Laurie R. Earls et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Widespread Protein Aggregation as an Inherent Part of Aging in C. elegans
Della C. David et al.
PLOS BIOLOGY (2010)
SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans
Chris R. Guthrie et al.
HUMAN MOLECULAR GENETICS (2009)
Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Yipeng Wang et al.
HUMAN MOLECULAR GENETICS (2009)
A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation
Dominik Paquet et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Intracellular amyloid formation in muscle cells of Aβ-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification
Alicia N. Minniti et al.
MOLECULAR NEURODEGENERATION (2009)
A Caenorhabditis elegans model of tau hyperphosphorylation: Induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau
Roland Brandt et al.
NEUROBIOLOGY OF AGING (2009)
Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging
Anat Ben-Zvi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2009)
Role of axonal transport in neurodegenerative diseases
Kurt J. De Vos et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
The invertebrate microtubule-associated protein PTL-1 functions in mechanosensation and development in Caenorhabditis elegans
Patricia Gordon et al.
DEVELOPMENT GENES AND EVOLUTION (2008)
The potential for β-structure in the repeat domain of Tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy
Maria-Magdalena Mocanu et al.
JOURNAL OF NEUROSCIENCE (2008)
The insulin paradox: aging, proteotoxicity and neurodegeneration
Ehud Cohen et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Tau-based treatment strategies in neurodegenerative diseases
Anja Schneider et al.
NEUROTHERAPEUTICS (2008)
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
Lars M. Ittner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans
Yunbileg Nyamsuren et al.
DEVELOPMENTAL BIOLOGY (2007)
The β-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy
Katrin Eckermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of τ aggregation and toxicity in vitro and in cells
Marcus Pickhardt et al.
BIOCHEMISTRY (2007)
SUT-1 enables tau-induced neurotoxicity in C-elegans
Brian C. Kraemer et al.
HUMAN MOLECULAR GENETICS (2007)
Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model
Y. P. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans
Cindy Voisine et al.
PLOS ONE (2007)
Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1
Edda Thies et al.
JOURNAL OF NEUROSCIENCE (2007)
Rhodanine-based tau aggregation inhibitors in cell models of tauopathy
Bruno Bulic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Amyloid-β-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans
Yanjue Wu et al.
JOURNAL OF NEUROSCIENCE (2006)
A genetic interaction between the vesicular acetylcholine transporter VAChT/UNC-17 and synaptobrevin/SNB-1 in C. elegans
GM Sandoval et al.
NATURE NEUROSCIENCE (2006)
Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans
BC Kraemer et al.
HUMAN MOLECULAR GENETICS (2006)
Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs
I Khlistunova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay
Timothy R. Mahoney et al.
NATURE PROTOCOLS (2006)
Progressive neurodegeneration in C-elegans model of tauopathy
T Miyasaka et al.
NEUROBIOLOGY OF DISEASE (2005)
Identification and characterization of novel nicotinic receptor-associated proteins in Caenorhabditis elegans
A Gottschalk et al.
EMBO JOURNAL (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins
S Taniguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Phosphorylated tau and the neurodegenerative foldopathies
KS Kosik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Axonal transport defects: a common theme in neurodegenerative diseases
S Roy et al.
ACTA NEUROPATHOLOGICA (2005)
MARK/PAR1 kinase is a regulator of microtubuledependent transport in axons
EM Mandelkow et al.
JOURNAL OF CELL BIOLOGY (2004)
Caenorhabditis elegans MPP+ Model of Parkinson's Disease for High-Throughput Drug Screenings
Evelyn Braungart et al.
NEURODEGENERATIVE DISEASES (2004)
Defects in synaptic vesicle docking in unc-18 mutants
RM Weimer et al.
NATURE NEUROSCIENCE (2003)
Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy
BC Kraemer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Axonal transport of membranous. and nonmembranous cargoes: a unified perspective
A Brown
JOURNAL OF CELL BIOLOGY (2003)
Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress
K Stamer et al.
JOURNAL OF CELL BIOLOGY (2002)
Synaptogenesis: insights from worm and fly
YS Jin
CURRENT OPINION IN NEUROBIOLOGY (2002)
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
JC Augustinack et al.
ACTA NEUROPATHOLOGICA (2002)
Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure
M von Bergen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
